Sublingual buprenorphine
- 17 September 1982
- journal article
- research article
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 20 (19) , 74-76
- https://doi.org/10.1136/dtb.20.19.74
Abstract
Buprenorphine is now marketed as a sublingual tablet (Temgesic Sublingual - Reckitt & Colman). The manufacturer describes it as a ‘strong analgesic for the relief of moderate to severe pain’.Keywords
This publication has 0 references indexed in Scilit: